Breaking News
Translate

Sanofi aventis’ re-launches flagyl

After few years it went off the market, owing to restructuring and progressive research on the treatment of diseases resulting from anaerobic infection, Sanofi aventins Nigeria, recently re-introduced one of its oldest brands into the country’s market, Flagyl, to keep pace with its numerous customers.

The re-launch of the product, held amid fun fare at the Welcome Centre and Hotel, Lagos, attracted  professionals in the fields of paediatrics, general medicine practice, pharmacy, medical laboratory science and Nursing as well as the Lagos State Ministry of Health and National Agency for Food and Drug Administration and Control (NAFDAC).

In his opening address, the company’s head of operations, East/Anglophone West Africa, Mr. Colin R. Smith, described flagyl as a brand that has stood the taste of time, adding, that for over 30 years, the brand was launched all over the world, it has remained a dependable product that is devoid of any meaningful rivals.

Being  one of the oldest pharmaceutical companies across the world, Mr. Smith said, his company   deemed it important to re-introduce the flagyl brand into the Nigerian market following the fact that the product has become a household name in many homes in the country.
Also, speaking in the same vein, Mr. Louis Ekomo, Brand Manager, Flagyl described the product as ‘the gold standard on the treatment of parasitic diarrhoea., gynaecological infections and anaerobic bacterial infections.’ He said, it is metronidazole, an effective and valued defense against bacterial infection.
‘It is used to effectively kill anaerobic (low oxygen) bacteria and certain parasites in humans.
According to him, areas of the body which may harbor anaerobic bacteria include the liver, abdomen and pelvis.’ he stressed, adding that ‘infection within these regions that are commonly treated with the antibiotic.’
Ekome however pointed out that flagyl works best when constant levels of the drugs are maintained in the bloodstream.


Disclaimer

Comments expressed here do not reflect the opinions of vanguard newspapers or any employee thereof.